Genome therapy could lead to new treatment for life-threatening blood disorders
Monday, July 17, 2017 - 10:32
in Health & Medicine
By introducing a beneficial natural mutation into blood cells using the gene-editing technique CRISPR, scientists have been able to switch on production of fetal haemoglobin - an advance that could eventually lead to a cure for sickle cell anaemia and other blood disorders.